Literature DB >> 28768726

Cutting Edge: 2B4-Mediated Coinhibition of CD4+ T Cells Underlies Mortality in Experimental Sepsis.

Ching-Wen Chen1,2,3, Rohit Mittal1, Nathan J Klingensmith1, Eileen M Burd4, Cox Terhorst5, Greg S Martin6, Craig M Coopersmith1,3, Mandy L Ford7,2.   

Abstract

Sepsis is a leading cause of death in the United States, but the mechanisms underlying sepsis-induced immune dysregulation remain poorly understood. 2B4 (CD244, SLAM4) is a cosignaling molecule expressed predominantly on NK cells and memory CD8+ T cells that has been shown to regulate T cell function in models of viral infection and autoimmunity. In this article, we show that 2B4 signaling mediates sepsis lymphocyte dysfunction and mortality. 2B4 expression is increased on CD4+ T cells in septic animals and human patients at early time points. Importantly, genetic loss or pharmacologic inhibition of 2B4 significantly increased survival in a murine cecal ligation and puncture model. Further, CD4-specific conditional knockouts showed that 2B4 functions on CD4+ T cell populations in a cell-intrinsic manner and modulates adaptive and innate immune responses during sepsis. Our results illuminate a novel role for 2B4 coinhibitory signaling on CD4+ T cells in mediating immune dysregulation.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28768726      PMCID: PMC5587400          DOI: 10.4049/jimmunol.1700375

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction.

Authors:  Nicholas J Shubin; Chun S Chung; Daithi S Heffernan; Lydea R Irwin; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2012-03-29       Impact factor: 4.962

2.  Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis.

Authors:  Pavan Brahmamdam; Shigeaki Inoue; Jacqueline Unsinger; Katherine C Chang; Jonathan E McDunn; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2010-05-18       Impact factor: 4.962

3.  Dose-dependent effect of anti-CTLA-4 on survival in sepsis.

Authors:  Shigeaki Inoue; Lulong Bo; Jinjun Bian; Jacqueline Unsinger; Katherine Chang; Richard S Hotchkiss
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

4.  Benchmarking the incidence and mortality of severe sepsis in the United States.

Authors:  David F Gaieski; J Matthew Edwards; Michael J Kallan; Brendan G Carr
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

5.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

6.  Cutting edge: an NK cell-independent role for Slamf4 in controlling humoral autoimmunity.

Authors:  Daniel R Brown; Silvia Calpe; Marton Keszei; Ninghai Wang; Shannon McArdel; Cox Terhorst; Arlene H Sharpe
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

7.  Differential alterations of tissue T-cell subsets after sepsis.

Authors:  Archna Sharma; Weng-Lang Yang; Shingo Matsuo; Ping Wang
Journal:  Immunol Lett       Date:  2015-09-08       Impact factor: 3.685

8.  PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis.

Authors:  Xin Huang; Fabienne Venet; Yvonne L Wang; Alain Lepape; Zhenglong Yuan; Yaping Chen; Ryan Swan; Hakim Kherouf; Guillaume Monneret; Chun-Shiang Chung; Alfred Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

9.  Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis.

Authors:  Anna Nolan; Hiroshi Kobayashi; Bushra Naveed; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Matthew R Karulf; William N Rom; Michael D Weiden; Jeffrey A Gold
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

10.  2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.

Authors:  Kyung-Mi Lee; Megan E McNerney; Susan E Stepp; Porunelloor A Mathew; John D Schatzle; Michael Bennett; Vinay Kumar
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  27 in total

1.  Sepsis erodes CD8+ memory T cell-protective immunity against an EBV homolog in a 2B4-dependent manner.

Authors:  Jianfeng Xie; Rebecca L Crepeau; Ching-Wen Chen; Wenxiao Zhang; Shunsuke Otani; Craig M Coopersmith; Mandy L Ford
Journal:  J Leukoc Biol       Date:  2019-01-09       Impact factor: 4.962

2.  Murine Pancreatic Cancer Alters T Cell Activation and Apoptosis and Worsens Survival After Cecal Ligation and Puncture.

Authors:  John D Lyons; Ching-Wen Chen; Zhe Liang; Wenxiao Zhang; Deena B Chihade; Eileen M Burd; Alton B Farris; Mandy L Ford; Craig M Coopersmith
Journal:  Shock       Date:  2019-06       Impact factor: 3.454

Review 3.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

4.  Increased attrition of memory T cells during sepsis requires 2B4.

Authors:  Jianfeng Xie; Ching-Wen Chen; Yini Sun; Sonia J Laurie; Wenxiao Zhang; Shunsuke Otani; Gregory S Martin; Craig M Coopersmith; Mandy L Ford
Journal:  JCI Insight       Date:  2019-05-02

5.  2B4 but not PD-1 blockade improves mortality in septic animals with preexisting malignancy.

Authors:  Ching-Wen Chen; Ming Xue; Wenxiao Zhang; Jianfeng Xie; Craig M Coopersmith; Mandy L Ford
Journal:  JCI Insight       Date:  2019-11-14

6.  The gut microbiome alters immunophenotype and survival from sepsis.

Authors:  Mandy L Ford; Craig M Coopersmith; Katherine T Fay; Nathan J Klingensmith; Ching-Wen Chen; Wenxiao Zhang; Yini Sun; Kristen N Morrow; Zhe Liang; Eileen M Burd
Journal:  FASEB J       Date:  2019-07-15       Impact factor: 5.191

Review 7.  A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis.

Authors:  Eleanor A Fallon; Bethany M Biron-Girard; Chun-Shiang Chung; Joanne Lomas-Neira; Daithi S Heffernan; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

8.  Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during Sepsis.

Authors:  Ching-Wen Chen; Kelsey B Bennion; David A Swift; Kristen N Morrow; Wenxiao Zhang; Takehiko Oami; Craig M Coopersmith; Mandy L Ford
Journal:  J Immunol       Date:  2021-04-28       Impact factor: 5.422

9.  CXCR4 blockade decreases CD4+ T cell exhaustion and improves survival in a murine model of polymicrobial sepsis.

Authors:  Kimberly M Ramonell; Wenxiao Zhang; Annette Hadley; Ching-Wen Chen; Katherine T Fay; John D Lyons; Nathan J Klingensmith; Kevin W McConnell; Craig M Coopersmith; Mandy L Ford
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

Review 10.  Sepsis and multiple sclerosis: Causative links and outcomes.

Authors:  Đorđe Miljković; Suzana Stanisavljević; Isaac J Jensen; Thomas S Griffith; Vladimir P Badovinac
Journal:  Immunol Lett       Date:  2021-07-25       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.